INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 33 filers reported holding INFLARX NV in Q4 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,304 | -33.2% | 4,800 | 0.0% | 0.00% | – |
| Q2 2023 | $21,408 | +129.9% | 4,800 | 0.0% | 0.00% | – |
| Q1 2023 | $9,312 | -37.4% | 4,800 | 0.0% | 0.00% | – |
| Q4 2022 | $14,880 | +14.5% | 4,800 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | +85.7% | 4,800 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -22.2% | 4,800 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -60.9% | 4,800 | 0.0% | 0.00% | – |
| Q4 2021 | $23,000 | +91.7% | 4,800 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | +200.0% | 4,800 | +300.0% | 0.00% | – |
| Q2 2021 | $4,000 | -100.0% | 1,200 | -58.6% | 0.00% | – |
| Q1 2021 | $11,310,000 | +102718.2% | 2,900 | +31.8% | 0.00% | – |
| Q4 2020 | $11,000 | +83.3% | 2,200 | +69.2% | 0.00% | – |
| Q3 2020 | $6,000 | -14.3% | 1,300 | -13.3% | 0.00% | – |
| Q2 2020 | $7,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,876,413 | $54,116,000 | 31.91% |
| RA Capital Management | 1,620,653 | $46,740,000 | 3.58% |
| Cormorant Asset Management, LP | 1,399,030 | $40,348,000 | 3.01% |
| EMORY UNIVERSITY | 90,761 | $2,618,000 | 1.87% |
| Redmile Group, LLC | 851,100 | $24,546,000 | 0.95% |
| Eventide Asset Management | 275,000 | $7,931,000 | 0.37% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,394,132 | $40,207,000 | 0.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,500 | $2,552,000 | 0.09% |
| Baker Brothers Advisors | 200,000 | $5,768,000 | 0.05% |
| Artal Group S.A. | 125,000 | $3,605,000 | 0.04% |